Drug Coverage Lookup

See how a prescription drug is placed across Medicare Part D plan formularies — tier, prior authorization, step therapy, and quantity limits, counted per unique plan.

Inbrija (Levodopa)

Aromatic Amino Acid

On Part D plan formularies — with restrictions

Found on the formularies of 3519 of 5499 Medicare Part D plans in this dataset · Tiers 1–6 · prior authorization on 3382 plans (96%) · quantity limits on 2392 (68%), counting a plan when at least one form/strength carries the flag.

This is dataset-wide formulary placement (data current through 2026-08-31) — check your specific plan for its current coverage and restrictions.

Found on the formularies of 3519 of 5499 Medicare Part D plans in this dataset, but prior authorization appears on 3382 of those 3519 plans (for at least one form/strength). Check your specific plan for its current rules, and learn what your prescriber needs to submit.
How prior authorization works →
PlanTierPrior AuthStep TherapyQty Limit
Hamaspik Medicare Choice (HMO D-SNP) (H0034-002) (NY) Tier 1 Yes No 300 per 30 days
MetroPlus UltraCare (HMO D-SNP) (H0423-007) (NY) Tier 1 Yes No 300 per 30 days
Mass General Brigham SCO (HMO D-SNP) (H0777-001) (MA) Tier 1 Yes No None
Johns Hopkins Advantage MD D-SNP (HMO D-SNP) (H1225-003) (MD) Tier 1 Yes No 300 per 30 days
CCA One Care (HMO D-SNP) (H1486-001) (MA) Tier 1 Yes No 300 per 30 days
Mass General Brigham One Care (HMO D-SNP) (H1611-001) (MA) Tier 1 Yes No None
Senior Whole Health SCO (HMO D-SNP) (H2224-001) (MA) Tier 1 Yes No 300 per 30 days
Senior Whole Health SCO NHC (HMO D-SNP) (H2224-003) (MA) Tier 1 Yes No 300 per 30 days
CCA Senior Care Options (HMO D-SNP) (H2225-001) (MA) Tier 1 Yes No 300 per 30 days
IMCare Classic (HMO D-SNP) (H2417-001) (MN) Tier 1 Yes No 300 per 30 days
SecureBlue (HMO D-SNP) (H2425-001) (MN) Tier 1 Yes No 300 per 30 days
Upper Peninsula Health Plan MI Coordinated Health (HMO D-SNP) (H3127-001) (MI) Tier 1 Yes No 300 per 30 days
Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) (H3251-029) (NM) Tier 1 Yes No 300 per 30 days
Elderplan Plus Long-Term Care (HMO-POS D-SNP) (H3347-007) (NY) Tier 1 Yes No 300 per 30 days
Healthfirst CompleteCare (HMO D-SNP) (H3359-034) (NY) Tier 1 Yes No 300 per 30 days
Provider Partners Pennsylvania Community Plan (HMO I-SNP) (H4093-004) (PA) Tier 1 Yes No None
HAP CareSource MI Coordinated Health (HMO D-SNP) (H4193-001) (MI) Tier 1 Yes No 300 per 30 days
Molina One Care (HMO D-SNP) (H4371-001) (MA) Tier 1 Yes No 300 per 30 days
Provider Partners North Carolina Community Plan (HMO I-SNP) (H4439-002) (NC) Tier 1 Yes No None
Provider Partners Indiana Community Plan (HMO I-SNP) (H4444-002) (IN) Tier 1 Yes No None
Mercy Care Advantage (HMO D-SNP) (H5580-001) (AZ) Tier 1 Yes No 300 per 30 days
Mercy Care Advantage (HMO D-SNP) (H5580-004) (AZ) Tier 1 Yes No 300 per 30 days
Mercy Care Advantage (HMO D-SNP) (H5580-005) (AZ) Tier 1 Yes No 300 per 30 days
Health Choice Pathway (HMO D-SNP) (H5587-002) (AZ) Tier 1 Yes No 300 per 30 days
ElderServe MAP (HMO D-SNP) (H6776-002) (NY) Tier 1 Yes No 300 per 30 days

One row per plan — showing 25 of 3519 plans; a Yes means the flag applies to at least one form/strength on that plan.

For benefits professionals
Plan sponsors and advisors: formulary-placement and utilization analysis across plans.
For benefits teams: plan formulary analysis →

Source: CMS Monthly Prescription Drug Plan Formulary and Pharmacy Network Information — data current through 2026-08-31 (CMS release 2026-08-26, refreshed monthly). Dataset-wide plan-year formulary placement, not a guarantee of your individual benefit — confirm with your plan or pharmacist.

Data: CMS Monthly Part D formulary files · FDA/RxNorm drug identity · CMS NADAC pricing — CMS Part D formulary data current through 2026-08-31 · source

Machine access — this tool is available as structured data for AI assistants and agents:
GET https://insurewith.ai/tools/drug-coverage/data.json?drug=levodopa
InsureWith Assistant
Hi! I can help you understand drug coverage, formulary tiers, prior authorization, and more. What would you like to know?